{"id":381208,"date":"2020-11-13T19:38:07","date_gmt":"2020-11-14T00:38:07","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=381208"},"modified":"2020-11-13T19:38:07","modified_gmt":"2020-11-14T00:38:07","slug":"tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\/","title":{"rendered":"Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">IRVINE, Calif., Nov.  13, 2020  (GLOBE NEWSWIRE) &#8212; Tarsus Pharmaceuticals, Inc. (\u201cTarsus\u201d NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye, today announced that Bobak Azamian, M.D., Ph.D., CEO of Tarsus, will present an overview of the company at the Jefferies Virtual London Healthcare Conference, being held November 17-19.<\/p>\n<p align=\"justify\">\n        <strong>Presentation Details <\/strong><br \/>\n        <br \/>\n        <strong>Date:<\/strong> Thursday, November 19<br \/><strong>Time:<\/strong> 11:10 AM GMT\/ 6:10 AM EST\/ 3:10 AM PST<br \/><strong>Webcast:<\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=S3SpoozMzfQ96hwAfvCXyGuEyBSSzOcwLjARtbHVnftZGzehuvaH6jhdDeHkCJd4p8-_vYB8zOH_KZu1rjqxXmnhyh67shUY8mCe2kPi6buiu3PBumryEd-ZMdvy7hcoK7TEOtjr3peRUysYm_e3zQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/wsw.com\/webcast\/jeff141\/tars\/1861050<\/a><\/p>\n<p>The live webcast will be hosted on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=f2nA2bzkdlL_bZtUpvxScZN9sHCF41Ws32tO4V9UIubXO3AnzELArqIWKck4NqC7\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">ir<\/a><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lk-welpwC3_L46Z4EY9RCQCOppbc3kj6UUiByWO-TmhQANMzXWNJFpBHwCp5SCedoIWb3DK1vqoyXVR-wNvYxA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">.tarsusrx.com<\/a> and available for replay for a period of 90 days.<\/p>\n<p>In addition to the presentation, the management team will host investor meetings at the conference. Investors participating in the conference who are interested in meeting with Tarsus should contact their Jefferies representative.<\/p>\n<p align=\"justify\">\n        <strong>About Tarsus Pharmaceuticals, Inc.<\/strong><br \/>\n        <strong>\u00a0<\/strong><br \/>\n        <br \/>Tarsus Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye. It is advancing its pipeline to address several diseases across therapeutic categories including eye care, dermatology, and other diseases with high, unmet needs. Its lead product candidate, TP-03, is a novel therapeutic in Phase\u00a02b\/3 that is being developed for the treatment of Demodex blepharitis.\u00a0For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lG1Gs7vqmHjhAvHCgQMQt3lAapzUB7sHvlQ5NQpt-G9e_BYyzdIn0f0h6rtaEd-2GZEbXY9_0mJeKeZCaUmxVQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.tarsusrx.com<\/a>.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong><br \/>\n        <br \/>Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute \u201cforward-looking statements.\u201d These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words, without limitation, \u201cbelieve,\u201d \u201ccontemplate,\u201d \u201ccontinue,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201cplan,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cshould,\u201d \u201ctarget,\u201d \u201cwill\u201d or \u201cwould\u201d or the negative of these terms or other similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these or similar identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and the completion of the public offering on the anticipated terms of the offering or at all, and other factors discussed in the \u201cRisk Factors\u201d section of the preliminary prospectus that forms a part of the effective registration statement filed with the SEC. Any forward-looking statements contained in this press release are based on the current expectations of Tarsus\u2019 management team and speak only as of the date hereof, and Tarsus specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.<\/p>\n<p align=\"justify\">\n        <strong>Media Contact: <\/strong><br \/>\n        <br \/>Allison Howell<br \/>Pascale Communications, LLC<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3MKwRgGaC16lBtUqHTl5quonn4OJ0pItbHNLZw5z4gvlh5z67ZhCBgiul2A1VK0KoaJW7RhXYZLWNZ601z_GhdXF1MKR-P7Kv1Joe8VvuNEloVNErIPOGgf-N9xadgie\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">allison@pascalecommunications.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjEwNSMzODI3MzAyIzIyMDM4NjQ=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/838112fb-a310-4f2c-a05c-08be97966704\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>IRVINE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) &#8212; Tarsus Pharmaceuticals, Inc. (\u201cTarsus\u201d NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye, today announced that Bobak Azamian, M.D., Ph.D., CEO of Tarsus, will present an overview of the company at the Jefferies Virtual London Healthcare Conference, being held November 17-19. Presentation Details Date: Thursday, November 19Time: 11:10 AM GMT\/ 6:10 AM EST\/ 3:10 AM PSTWebcast:https:\/\/wsw.com\/webcast\/jeff141\/tars\/1861050 The live webcast will be hosted on ir.tarsusrx.com and available for replay for a period of 90 days. In addition to the presentation, the management team will host investor meetings at the conference. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-381208","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"IRVINE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) &#8212; Tarsus Pharmaceuticals, Inc. (\u201cTarsus\u201d NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye, today announced that Bobak Azamian, M.D., Ph.D., CEO of Tarsus, will present an overview of the company at the Jefferies Virtual London Healthcare Conference, being held November 17-19. Presentation Details Date: Thursday, November 19Time: 11:10 AM GMT\/ 6:10 AM EST\/ 3:10 AM PSTWebcast:https:\/\/wsw.com\/webcast\/jeff141\/tars\/1861050 The live webcast will be hosted on ir.tarsusrx.com and available for replay for a period of 90 days. In addition to the presentation, the management team will host investor meetings at the conference. &hellip; Continue reading &quot;Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-14T00:38:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjEwNSMzODI3MzAyIzIyMDM4NjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference\",\"datePublished\":\"2020-11-14T00:38:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\\\/\"},\"wordCount\":468,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NjEwNSMzODI3MzAyIzIyMDM4NjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\\\/\",\"name\":\"Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NjEwNSMzODI3MzAyIzIyMDM4NjQ=\",\"datePublished\":\"2020-11-14T00:38:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NjEwNSMzODI3MzAyIzIyMDM4NjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NjEwNSMzODI3MzAyIzIyMDM4NjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference - Market Newsdesk","og_description":"IRVINE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) &#8212; Tarsus Pharmaceuticals, Inc. (\u201cTarsus\u201d NASDAQ: TARS), a late clinical-stage biopharmaceutical company whose mission is to discover and deliver breakthrough treatments to transform the lives of patients with common and poorly treated diseases, starting with the eye, today announced that Bobak Azamian, M.D., Ph.D., CEO of Tarsus, will present an overview of the company at the Jefferies Virtual London Healthcare Conference, being held November 17-19. Presentation Details Date: Thursday, November 19Time: 11:10 AM GMT\/ 6:10 AM EST\/ 3:10 AM PSTWebcast:https:\/\/wsw.com\/webcast\/jeff141\/tars\/1861050 The live webcast will be hosted on ir.tarsusrx.com and available for replay for a period of 90 days. In addition to the presentation, the management team will host investor meetings at the conference. &hellip; Continue reading \"Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-14T00:38:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjEwNSMzODI3MzAyIzIyMDM4NjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference","datePublished":"2020-11-14T00:38:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\/"},"wordCount":468,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjEwNSMzODI3MzAyIzIyMDM4NjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\/","name":"Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjEwNSMzODI3MzAyIzIyMDM4NjQ=","datePublished":"2020-11-14T00:38:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjEwNSMzODI3MzAyIzIyMDM4NjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NjEwNSMzODI3MzAyIzIyMDM4NjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tarsus-pharmaceuticals-inc-to-present-at-the-jefferies-virtual-london-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Tarsus Pharmaceuticals, Inc. to Present at the Jefferies Virtual London Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381208","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=381208"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/381208\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=381208"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=381208"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=381208"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}